Online Weight Management Programs: A Provider, Pharmacy, and Follow-Up Checklist

By TotalCareMedical.com Editorial Team | Sources checked October 1, 2026

The short answer: before you enroll in an online weight management program, get three things in writing. Find out who the licensed prescriber is, which pharmacy fills the prescription and whether the medication is FDA-approved or compounded. Then find out who you can reach after the medication arrives. The checklist below turns those questions into a sheet you can fill in for up to three programs.

TotalCareMedical.com is an independent publication. It is not a medical practice and does not provide clinical care, and no clinician reviewed this article. Use it to prepare questions for a licensed health care provider, not to decide what treatment is right for you.

Why the pharmacy and medication questions matter

Online programs can look alike from the outside. The details that differ most are often the ones that affect safety.

• According to the FDA, compounded drugs are not FDA-approved, which means the agency does not review their safety, effectiveness or quality before they are marketed.
• The FDA also says compounded drugs can serve an important medical need. If one does not meet quality standards, it could cause serious injury or death. Labels may also lack adequate directions for safe use.
• For compounded GLP-1 drugs such as semaglutide and tirzepatide, the FDA says compounded versions should be used only for patients whose medical needs cannot be met by an FDA-approved drug.
• The FDA recommends getting a prescription from your doctor and filling it at a state-licensed pharmacy.

Our weight management hub lists the telehealth program reviews on this site, which discuss the difference between compounded and FDA-approved medications. Some pages on this site contain affiliate links; this article does not.

Your three-column comparison sheet

Copy this into a note or document. Label your programs A, B and C. For each row, write down what the program tells you in writing, such as on its website, in its terms or in a reply to your message. If a program will not answer a row, write “no answer.” That is useful information too.

Provider

• Is a licensed doctor involved before any medication is prescribed? A: ____ | B: ____ | C: ____
• What screening happens first (health history, current medications, conditions)? A: ____ | B: ____ | C: ____
• Is a licensed doctor available to answer questions after the medication arrives? A: ____ | B: ____ | C: ____

Pharmacy and medication

• Is the medication an FDA-approved drug or a compounded drug? A: ____ | B: ____ | C: ____
• What is the name and location of the pharmacy, and is it state-licensed? A: ____ | B: ____ | C: ____
• Does the program claim the compounded drug is the same as an FDA-approved drug? A: ____ | B: ____ | C: ____
• What are the storage and shipping instructions (refrigeration, packaging)? A: ____ | B: ____ | C: ____
• If it comes in a multi-dose vial, what does the label say about how long to use it? A: ____ | B: ____ | C: ____
• Who explains how to measure and give each dose? A: ____ | B: ____ | C: ____

Follow-up and support

• How do I reach the care team (message, phone, video), and what are the hours? A: ____ | B: ____ | C: ____
• Who adjusts my dose if I have side effects? A: ____ | B: ____ | C: ____
• What happens if I stop the program or need to cancel? A: ____ | B: ____ | C: ____
• Does the program tell me how to report a problem with the medication? A: ____ | B: ____ | C: ____

Red flags the FDA lists for telehealth companies

The FDA lists warning signs for consumers to look for. Be cautious if a company:

• says its compounded drug is the same as an FDA-approved drug
• offers medicine at deep discounts or prices that seem too good to be true
• does not require screening and a prescription by a licensed doctor before providing medicine
• does not have a licensed doctor available to answer questions after you receive your medication
• sends medicine that looks different from what you have received at your local pharmacy or what was pictured on its website, or that arrives in broken or damaged packaging or without instructions for use
• has spelling errors on the label or gives incorrect addresses for the pharmacy

The FDA also warns about products sold online that are falsely labeled “for research purposes” or “not for human consumption.” It urges consumers not to buy them because their quality is unknown and they may be harmful.

Safety details to check once medication arrives

• Temperature: The FDA says injectable GLP-1 drugs require refrigeration. It has received complaints of compounded products arriving warm or with inadequate ice packs, and it recommends not using any injectable GLP-1 drug that arrives warm or insufficiently refrigerated.
• Multi-dose vials: The FDA recommends discarding a vial within 28 days after first use, even if medication remains. It says this holds even if the compounder's instructions allow longer use. It also recommends a new, sterile needle and syringe for every dose.
• Dosing: The FDA has received reports of adverse events, some requiring hospitalization, that may be related to dosing errors with compounded injectable semaglutide. It encourages patients to ask their provider or compounder how to measure and give the intended dose.
• Reporting: The FDA encourages patients and providers to report adverse events or quality problems through its MedWatch program. It notes that federal law does not require state-licensed pharmacies that are not outsourcing facilities to submit adverse events, so reports from compounded products are likely underreported.

If the program includes supplements

Some programs add dietary supplements to a plan. The FDA says it regulates dietary supplements under different regulations than conventional foods and drug products. Manufacturers and distributors are responsible for evaluating the safety and labeling of their products before marketing. The FDA can act against an adulterated or misbranded supplement after it reaches the market. Ask the program to list every ingredient, and tell your prescriber and pharmacist about anything you take.

Who should talk to a professional first

Talk with a licensed health care provider before starting, changing or stopping any weight management medication or supplement, especially if you take other medications or have an ongoing medical condition. If a medication causes a reaction or you are worried about a product you received, contact your prescriber or pharmacist and consider reporting it to the FDA.

What to do next

1. Pick up to three programs and fill in the sheet from their own written materials.
2. Send any unanswered rows to the program and note how, and how quickly, it responds.
3. Bring the completed sheet to your own doctor or pharmacist and ask whether the plan fits your health history.
4. If a program fails several rows, treat that as a reason to keep looking. You don't owe any program an enrollment.

For more on how we evaluate programs, see our editorial standards and our telehealth platform reviews.

Sources

All sources were opened and checked on October 1, 2026.

• U.S. FDA, Understanding the Risks of Compounded Drugs (content current as of 06/22/2026)
• U.S. FDA, FDA's Concerns with Unapproved GLP-1 Drugs Used for Weight Loss (content current as of 09/01/2026)
• U.S. FDA, Dietary Supplements (content current as of 10/01/2024)

TotalCareMedical.com is an independent health and wellness research publication. It is not a medical practice or healthcare provider. The domain was previously owned by a medical center no longer associated with this website. This content is educational only and is not medical advice, diagnosis or treatment.